Top Markets
Coin of the day
TaiRx, Inc. TaiRx, Inc.

TaiRx, Inc.

6580
Classifica tra le azioni #25983
TaiRx, Inc., established in 2011 and headquartered in Taipei City, Taiwan, is a... TaiRx, Inc., established in 2011 and headquartered in Taipei City, Taiwan, is a pharmaceutical company dedicated to the research, development, and commercialization of therapeutic solutions for cancer and other diseases. The company's clinical pipeline includes CVM-1118, an oral anti-cancer drug currently undergoing Phase II clinical trials, and Rexis, an add-on injection therapy for sepsis patients, which is in Phase III trials. In its pre-clinical stage, TaiRx is developing TRX-711 for secondary hyperparathyroidism, TRX-920 as an oral delivery formulation, and TRX-105, a molecule designed to treat and alleviate symptoms of various types of colitis. Beyond its developmental drugs, TaiRx also offers Zelnite, a medication that helps maintain patients' blood selenium levels and supports their immune systems. The company's future endeavors also involve the development of nodal diagnostic devices and innovative antibody-based drugs.
Prezzo delle azioni
$0.3990778
Capitalizzazione di mercato
$44.74M
Variazione (1 giorno)
-2.33%
Variazione (1 anno)
-46.32%
Paese
TW
Scambia TaiRx, Inc. (6580)

Categoria

Cronologia dei frazionamenti azionari per TaiRx, Inc. (6580)
L’azione TaiRx, Inc. (simbolo: 6580) ha subito un totale di 0 frazionamenti.
L’ultimo frazionamento è avvenuto il Aug 21, 2026.
Una quota di 6580 acquistata prima di Aug 21, 2026 equivale oggi a 0 quote di 6580.
Elenco dei frazionamenti azionari
Anno Frazionamento Moltiplicatore Moltiplicatore cumulativo
Non abbastanza dati per le date fornite.
Frazionamenti azionari di aziende simili o concorrenti
Azienda Numero di frazionamenti azionari Moltiplicatore cumulativo Il paese
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
US